Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013, Article ID 939047, 8 pages
http://dx.doi.org/10.1155/2013/939047
Clinical Study

Differential IL-13 Production by Small Intestinal Leukocytes in Active Coeliac Disease versus Refractory Coeliac Disease

1Department of Pathology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands
2Department of Gastroenterology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands

Received 2 February 2013; Accepted 4 March 2013

Academic Editor: David Bernardo Ordiz

Copyright © 2013 Sascha Gross et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. De Re, L. Caggiari, M. Tabuso, and R. Cannizzaro, “The versatile role of gliadin peptides in celiac disease,” Clinical Biochemistry, 2012. View at Publisher · View at Google Scholar
  2. B. Meresse, G. Malamut, and N. Cerf-Bensussan, “Celiac disease: an immunological jigsaw,” Immunity, vol. 36, no. 6, pp. 907–919, 2012. View at Google Scholar
  3. M. V. Barone, D. Zanzi, M. Maglio et al., “Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking,” PLoS One, vol. 6, no. 2, Article ID e17039, 2011. View at Google Scholar
  4. J. M. Laparra Llopis and Y. Sanz Herranz, “Gliadins induce TNFα production through cAMP-dependent protein kinase A activation in intestinal cells (Caco-2),” Journal of Physiology and Biochemistry, vol. 66, no. 2, pp. 153–159, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Bernardo, J. A. Garrote, L. Fernández-Salazar, S. Riestra, and E. Arranz, “Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides,” Gut, vol. 56, no. 6, pp. 889–890, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Abadie, V. Discepolo, and B. Jabri, “Intraepithelial lymphocytes in celiac disease immunopathology,” Seminars in Immunopathology, vol. 34, no. 4, pp. 551–566, 2012. View at Google Scholar
  7. R. W. Olaussen, F. E. Johansen, K. E. A. Lundin, J. Jahnsen, P. Brandtzaeg, and I. N. Farstad, “Interferon-γ-secreting T cells localize to the epithelium in coeliac disease,” Scandinavian Journal of Immunology, vol. 56, no. 6, pp. 652–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Bayardo, F. Punzi, C. Bondar, N. Chopita, and F. Chirdo, “Transglutaminase 2 expression is enhanced synergistically by interferon-gamma and tumour necrosis factor-alpha in human small intestine,” Clinical & Experimental Immunology, vol. 168, no. 1, pp. 95–104, 2012. View at Google Scholar
  9. S. Dørum, S. W. Qiao, L. M. Sollid, and B. Fleckenstein, “A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the t-cell response in celiac disease,” Journal of Proteome Research, vol. 8, no. 4, pp. 1748–1755, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Bodd, M. Ráki, S. Tollefsen et al., “HLA-DQ2-restricted gluten-reactive T cells produce IL-21 but not IL-17 or IL-22,” Mucosal Immunology, vol. 3, no. 6, pp. 594–601, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. M. C. Wapenaar, M. J. van Belzen, J. H. Fransen et al., “The interferon gamma gene in celiac disease: augmented expression correlates with tissue damage but no evidence for genetic susceptibility,” Journal of Autoimmunity, vol. 23, no. 2, pp. 183–190, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Furuta, H. Goto, Y. Niwa et al., “Interferon-γ regulates apoptosis by releasing soluble tumor necrosis factor receptors in a gastric epithelial cell line,” Journal of Gastroenterology and Hepatology, vol. 17, no. 12, pp. 1283–1290, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. I. Monteleone, M. Sarra, G. D. V. Blanco et al., “Characterization of IL-17A-producing cells in celiac disease mucosa,” Journal of Immunology, vol. 184, no. 4, pp. 2211–2218, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Forsberg, O. Hernell, S. Hammarström, and M. L. Hammarström, “Concomitant increase of IL-10 and pro-inflammatory cytokines in intraepithelial lymphocyte subsets in celiac disease,” International Immunology, vol. 19, no. 8, pp. 993–1001, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. C. J. J. Mulder, P. J. Wahab, J. W. R. Meijer, and E. Metselaar, “A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease,” European Journal of Gastroenterology and Hepatology, vol. 13, no. 10, pp. 1183–1188, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Malamut, B. Meresse, C. Cellier, and N. Cerf-Bensussan, “Refractory celiac disease: from bench to bedside,” Seminars in Immunopathology, vol. 34, no. 4, pp. 601–613, 2012. View at Google Scholar
  17. W. H. M. Verbeek, M. S. Goerres, B. M. E. von Blomberg et al., “Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease,” Clinical Immunology, vol. 126, no. 1, pp. 48–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Malamut, R. El Machhour, N. Montcuquet et al., “IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis,” The Journal of Clinical Investigation, vol. 120, no. 6, pp. 2131–2143, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. R. W. Olaussen, F. E. Johansen, K. E. A. Lundin, J. Jahnsen, P. Brandtzaeg, and I. N. Farstad, “Interferon-γ-secreting T cells localize to the epithelium in coeliac disease,” Scandinavian Journal of Immunology, vol. 56, no. 6, pp. 652–664, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Costantino, A. della Torre, M. A. Lo Presti, R. Caruso, E. Mazzon, and W. Fries, “Treatment of life-threatening type I refractory coeliac disease with long-term infliximab,” Digestive and Liver Disease, vol. 40, no. 1, pp. 74–77, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. R. Gillett, I. D. R. Arnott, M. McIntyre et al., “Successful infliximab treatment for steroid-refractory celiac disease: a case report,” Gastroenterology, vol. 122, no. 3, pp. 800–805, 2002. View at Google Scholar · View at Scopus
  22. C. J. J. Mudler, “When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001,” European Journal of Gastroenterology and Hepatology, vol. 13, no. 9, pp. 1123–1128, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. G. J. Tack, R. L. van Wanrooij, A. W. Langerak et al., “Origin and immunophenotype of aberrant IEL in RCDII patients,” Molecular Immunology, vol. 50, no. 4, pp. 262–270, 2012. View at Google Scholar
  24. W. H. M. Verbeek, M. S. Goerres, B. M. E. von Blomberg et al., “Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease,” Clinical Immunology, vol. 126, no. 1, pp. 48–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Bergamaschi, J. Bear, M. Rosati et al., “Circulating IL-15 exists as heterodimeric complex with soluble IL-15Ralpha in human and mouse serum,” Blood, vol. 120, no. 1, pp. e1–e8, 2012. View at Google Scholar
  26. G. Forsberg, O. Hernell, S. Melgar, A. Israelsson, S. Hammarström, and M. Hammarström, “Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease,” Gastroenterology, vol. 123, no. 3, pp. 667–678, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. F. León, L. Sánchez, C. Camarero, and G. Roy, “Cytokine production by intestinal intraepithelial lymphocyte subsets in celiac disease,” Digestive Diseases and Sciences, vol. 50, no. 3, pp. 593–600, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Kontakou, R. T. Przemioslo, R. P. Sturgess, A. G. Limb, and P. J. Ciclitira, “Expression of tumour necrosis factor-α, interleukin-6, and interleukin-2 mRNA in the jejunum of patients with coeliac disease,” Scandinavian Journal of Gastroenterology, vol. 30, no. 5, pp. 456–463, 1995. View at Google Scholar · View at Scopus
  29. R. T. Przemioslo, M. Kontakou, V. Nobili, and P. J. Ciclitira, “Raised pro-inflammatory cytokines interleukin 6 and tumour necrosis factor α in coeliac disease mucosa detected by immunohistochemistry,” Gut, vol. 35, no. 10, pp. 1398–1403, 1994. View at Google Scholar · View at Scopus
  30. R. La Scaleia, M. Barba, G. Di Nardo et al., “Size and dynamics of mucosal and peripheral IL-17A+ T-cell pools in pediatric age, and their disturbance in celiac disease,” Mucosal Immunology, vol. 5, no. 5, pp. 513–523, 2012. View at Google Scholar
  31. K. Hirota, H. Ahlfors, J. H. Duarte, and B. Stockinger, “Regulation and function of innate and adaptive interleukin-17-producing cells,” EMBO Reports, vol. 13, no. 2, pp. 113–120, 2012. View at Google Scholar
  32. P. Mannon and W. Reinisch, “Interleukin 13 and its role in gut defence and inflammation,” Gut, vol. 61, no. 12, pp. 1765–1773, 2012. View at Google Scholar
  33. I. J. Fuss, F. Heller, M. Boirivant et al., “Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis,” The Journal of Clinical Investigation, vol. 113, no. 10, pp. 1490–1497, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Heller, A. Fromm, A. H. Gitter, J. Mankertz, and J. D. Schulzke, “Epithelial apoptosis is a prominent feature of the epithelial barrier disturbance in intestinal inflammation: effect of pro-inflammatory interleukin-13 on epithelial cell function,” Mucosal Immunology, vol. 1, supplement 1, pp. S58–S61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. P. Mannon and W. Reinisch, “Interleukin 13 and its role in defence and inflammation,” Gut, vol. 61, no. 12, pp. 1765–1773, 2012. View at Google Scholar
  36. D. Bernardo, J. A. Garrote, Y. Allegretti et al., “Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients,” Clinical & Experimental Immunology, vol. 154, no. 1, pp. 64–73, 2008. View at Google Scholar